FOLFOX regimen (hepatic artery infusion)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FOLFOX regimen (hepatic artery infusion), covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma [Phase 2]